Detalhe da pesquisa
1.
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
Am J Respir Crit Care Med
; 208(4): 417-427, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37411039
2.
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Cancer
; 129(14): 2256-2265, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151113
3.
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e.âV.] / S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023.
Pneumologie
; 77(8): 461-543, 2023 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-37406667
4.
AVAiLABLE NIS - AVASTIN® in lung cancer treatment in routine oncology practice in Germany.
BMC Cancer
; 19(1): 433, 2019 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077164
5.
Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial.
Respiration
; 97(4): 292-301, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391944
6.
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e.âV.] / Erratum: S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023.
Pneumologie
; 77(8): e3, 2023 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-38513695
7.
High strength extrafine pMDI beclometasone/formoterol (200/6 µg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
BMC Pulm Med
; 16(1): 180, 2016 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27938358
8.
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
Thorax
; 70(4): 311-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677679
9.
The influence of anti-cancer therapies on lymphocyte subpopulations of lung cancer patients.
Front Immunol
; 14: 1239097, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701442
10.
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
J Asthma Allergy
; 16: 123-134, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714049
11.
Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany - The TriOptimize Study.
Int J Chron Obstruct Pulmon Dis
; 17: 3019-3031, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483674
12.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 38(12): 2191-2199, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36047998
13.
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.
Nat Med
; 28(11): 2374-2380, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008722
14.
Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies.
Oncol Res Treat
; 44(3): 93-102, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33477145
15.
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
Respir Med
; 180: 106311, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711782
16.
[Substitution exclusion of inhalatives]. / Substitutionsausschluss von Inhalativa.
Med Monatsschr Pharm
; 38(6): 237-8; discussion 238, 2015 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-26364377
17.
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).
Respir Med
; 170: 106021, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843164
18.
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
Lancet Respir Med
; 8(10): 987-999, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653075
19.
[Rapid effectiveness and better medication compliance]. / Rasche Wirkung und bessere Therapietreue.
MMW Fortschr Med
; 156(17): 67, 2014 Oct 09.
Artigo
em Alemão
| MEDLINE | ID: mdl-25417481
20.
Rasche Wirkung und bessere Therapietreue.
MMW Fortschr Med
; 156(17): 67, 2014 Oct 09.
Artigo
em Alemão
| MEDLINE | ID: mdl-25507209